Short description
PExA develops, produces, and markets a research instrument for studying respiratory diseases.
Description
PExA develops, produces and markets a research instrument for studying respiratory diseases such as asthma and chronic obstructive pulmonary disease, COPD.
The original idea and research behind the method comes from Professor Anna-Carin Olin's research team at the University of Gothenburg University of Technology at the Sahlgrenska Academy of Occupational and Environmental Medicine (AMM) and is based on a whole new method of collecting small airway materials: particles in exhalation air. A subsequent analysis of the particles makes it possible to easily identify chemical changes in the composition and identify potential biomarkers for lung diseases
PExA provides lung researchers with a simple and non-invasive method (ie no bodily intervention) for the collection of microscopic particles, potential biomarkers for diseases in the small respiratory tract. The method allows researchers to easily access a sample from the liquid layer covering the small respiratory tract. The aim is to facilitate the development of reliable and more individualized diagnosis, monitoring and treatment of respiratory diseases.
Last funding
Noway Youcantaccess
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
Gothenburg, Vastra Gotaland, Sweden, Europe
Founded on
January 1, 2014
Non-profit?
No
Acquired?
No
Employees count
1-10
Revenue range
$34056 - 789030
Sign in for full access
Investors
Noaccess
Sign in for full access
Founders
Anna Carin Olin